FIGURE: 1 / 2
MA5-17110 targets LMO2 in FACS, pep-ELISA, and WB applications and shows reactivity with Human samples.
The MA5-17110 immunogen is purified recombinant fragment of human LMO2 (amino acids: 1-158) expressed in E. Coli.
MA5-17110 detects LMO2 which has a predicted molecular weight of approximately 18.4kDa.
LMO2 encodes a cysteine-rich, two LIM-domain protein that is required for yolk sac erythropoiesis. The LMO2 protein has a central and crucial role in hematopoietic development and is highly conserved. The LMO2 transcription start site is located approximately 25 kb downstream from the 11p13 T-cell translocation cluster (11p13 ttc), where a number T-cell acute lymphoblastic leukemia-specific translocations occur. Alternative splicing results in multiple transcript variants encoding different isoforms.
Protein Aliases: Cysteine-rich protein TTG-2; LIM domain only 2 (rhombotin-like 1); LIM domain only protein 2; LMO-2; rhombotin 2; Rhombotin-2; rhombotin-like 1; T-cell translocation gene 2; T-cell translocation protein 2
Gene Aliases: LMO2; RBTN2; RBTNL1; RHOM2; TTG2
UniProt ID: (Human) P25791
Entrez Gene ID: (Human) 4005